FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan ...
Tag: Weight
New White House rule would make weight loss drugs available for people on Medicare and Medicaid
New White House rule would make weight loss drugs available for people on Medicare and Medicaid - CBS News
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs
Ozempic, Wegovy popularity leads to rise of fake weight loss drugs - CBS News
Weight loss drugs could help patients struggling with addiction, study says
Weight loss drugs could help patients struggling with addiction, study says - CBS News
As weight loss drugs explode in popularity, are online marketplaces safe?
As weight loss drugs explode in popularity, are online marketplaces safe? - CBS News
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks.It is behind the GLP-1, Obesity & Cardiometabolic ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
This new weight loss drug ETF bets big on two of the industry’s leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments' GLP-1 & Weight ...
Hims & Hers says it’s selling a GLP-1 weight loss drug for 85% less than Wegovy. Here’s the price.
Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of ...
